R Windsor, A Hamilton, A McTiernan, P Dileo… - European Journal of …, 2022 - Elsevier
Background outcome of primary refractory or recurrent Ewing sarcoma (RRES) is poor and
the role of high-dose therapy (HDT) remains uncertain. We retrospectively reviewed all …